Company Number: 13625849

Analysis Date: 2025-07-29 12:43 UTC

1. Risk Rating: LOW
   The company demonstrates a stable and positive net asset position with a consistent increase in net current assets and shareholders' funds over the last three years. There are no overdue accounts or confirmation statements, indicating compliance with regulatory requirements.

2. Key Concerns:

• Limited scale and scope: As a micro-entity with only 2 employees and minimal fixed assets, the business may have limited operational scale and resilience.
• Lack of audit and detailed financial disclosures: Micro-entity exemption means less transparency, which may obscure detailed financial risks or operational issues.
• Industry risks: Classified under "Other human health activities," which may face regulatory and market changes; however, specific operational details are not provided to assess this risk fully.

3. Positive Indicators:

• Strong liquidity position with net current assets of £15,719 as of the latest year-end, indicating the company can meet short-term liabilities comfortably.
• Growth in net assets and shareholders' funds from £7,514 in 2021 to £15,993 in 2024, showing capital accumulation and potentially retained earnings.
• No overdue filings and active status with up-to-date confirmation statements, reflecting good governance and regulatory compliance.

4. Due Diligence Notes:

• Review detailed operational and revenue data to assess sustainability and growth prospects beyond balance sheet figures.
• Investigate any contingent liabilities or off-balance-sheet risks not disclosed in micro-entity accounts.
• Understand the impact of sector-specific regulatory requirements on the company's business model and compliance costs.